Filing Details
- Accession Number:
- 0001415889-23-006920
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-26 16:17:05
- Reporting Period:
- 2023-04-24
- Accepted Time:
- 2023-04-26 16:17:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1109354 | Bruker Corp | BRKR | Laboratory Analytical Instruments (3826) | 043110160 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1133649 | H Frank Laukien | C/O Bruker Corporation 40 Manning Road Billerica MA 01821 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-04-24 | 146,122 | $81.01 | 38,352,034 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-24 | 2,108 | $81.65 | 38,349,926 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-25 | 13,793 | $77.87 | 38,298,156 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-25 | 30,343 | $79.06 | 38,269,921 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-25 | 7,174 | $79.82 | 38,262,747 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-25 | 460 | $80.64 | 38,262,287 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,046,499 | Indirect | By Former Spouse |
Common Stock | 337,087 | Indirect | By Son |
Common Stock | 336,607 | Indirect | By Daughter |
Common Stock | 201,702 | Indirect | As UTMA Custodian for Son |
Common Stock | 71,728 | Indirect | As UTMA Custodian for Son |
Common Stock | 492 | Indirect | By Former Spouse |
Footnotes
- The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.57 to $81.52, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.585 to $81.93, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.51 to $78.45, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.515 to $79.50, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.51 to $80.35, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.58 to $80.67, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.